You have probably heard about Latisse, the eyelash grower that's been on the market since the FDA approved it in December 2008. Celebrities such as Jenny McCarthy, Mandy Moore have reportedly used Latisse, and its advertising spokespeople have included Brooke Shields and Claire Danes.
Latisse is actually a version of a glaucoma drug in eye drop form called bimatoprost (brand name Lumigan, manufacturer Allergan, Inc.), in use since FDA approval in 2001. During that period, eye doctors and their glaucoma patients noticed the hair growth side effect, with longer, lusher eyelashes appearing over time.
Typical results: longer, fuller, darker eyelashes
Cost: $135 for a one-month supply